Characterization of T-Cell Immune Responses in Clinical Trials of the Candidate RTS,S Malaria Vaccine

Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2017.1381809
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Pooled Analysis of Safety Data From Pediatric Phase II RTS,S/AS Malaria Candidate Vaccine Trials

Human Vaccines
2011English

Systems Analysis of Protective Immune Responses to RTS,S Malaria Vaccination in Humans

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2017English

A Combined Analysis of Immunogenicity, Antibody Kinetics and Vaccine Efficacy From Phase 2 Trials of the RTS,S Malaria Vaccine

BMC Medicine
Medicine
2014English

Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants

New England Journal of Medicine
Medicine
2008English

Policy Analysis for Deciding on a Malaria Vaccine RTS,S in Tanzania

Malaria Journal
ParasitologyInfectious Diseases
2016English

Assessment of Severe Malaria in a Multicenter, Phase III, RTS, S/As01 Malaria Candidate Vaccine Trial: Case Definition, Standardization of Data Collection and Patient Care

Malaria Journal
ParasitologyInfectious Diseases
2011English

The RTS,S/AS01 Malaria Vaccine in Children 5 to 17 Months of Age at First Vaccination

Expert Review of Vaccines
Molecular MedicineDrug DiscoveryImmunologyPharmacology
2016English

T-Cell Epitopes in Pf155/Resa, a Major Candidate for a Plasmodium Falciparum Malaria Vaccine.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1988English

Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area

PLoS ONE
Multidisciplinary
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy